CNBC·2025-12-01 19:38Market Update - The stock market started December slightly lower after a strong Thanksgiving week, with the S&P 500 rallying almost 4%, marking its seventh consecutive month of gains [1] - The Nasdaq increased over 4% last week but fell 1.5% in November, ending its seven-month winning streak [1] Eli Lilly Price Cuts - Eli Lilly announced a price reduction for its obesity medication Zepbound, with the starting dose now priced at $299 per month, down from $349, and the 5 mg dose at $399, down from $499 [1] - Analysts at Leerink noted that the price cuts may have come earlier than expected but are not a major surprise, emphasizing the potential for expanded patient access to Lilly's drugs [1] - The price reductions are part of a broader trend in the GLP-1 market, with Novo Nordisk also cutting prices to regain market share [1] - The expectation is that lost revenue from price cuts will be compensated by increased volume, supporting Eli Lilly's earnings-per-share growth in the coming years [1] Goldman Sachs Acquisition - Goldman Sachs announced plans to acquire Innovator Capital Management for $2 billion, a pioneer in defined outcome exchange-traded funds (ETFs) [1] - Innovator has created the first defined outcome ETF and has $28 billion in assets under supervision as of September 30 [1] - The acquisition aims to significantly expand Goldman Sachs Asset Management's ETF lineup and enhance offerings in a rapidly growing active ETF category [1] - This acquisition follows a previous deal with T. Rowe Price to create private market products for investors, indicating a strategic push in Goldman's asset and wealth management division [1] Upcoming Earnings Reports - MongoDB is set to report earnings after the market closes on Monday, while United Natural Foods and Signet Jewelers will release results before Tuesday's opening bell [1]